1
|
Bellavita R, Braccia S, Falanga A, Galdiero S. An Overview of Supramolecular Platforms Boosting Drug Delivery. Bioinorg Chem Appl 2023; 2023:8608428. [PMID: 38028018 PMCID: PMC10661875 DOI: 10.1155/2023/8608428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 07/03/2023] [Accepted: 10/26/2023] [Indexed: 12/01/2023] Open
Abstract
Numerous supramolecular platforms inspired by natural self-assembly are exploited as drug delivery systems. The spontaneous arrangement of single building blocks into inorganic and organic structures is determined and controlled by noncovalent forces such as electrostatic interactions, π-π interactions, hydrogen bonds, and van der Waals interactions. This review describes the main structures and characteristics of several building blocks used to obtain stable, self-assembling nanostructures tailored for numerous biological applications. Owing to their versatility, biocompatibility, and controllability, these nanostructures find application in diverse fields ranging from drug/gene delivery, theranostics, tissue engineering, and nanoelectronics. Herein, we described the different approaches used to design and functionalize these nanomaterials to obtain selective drug delivery in a specific disease. In particular, the review highlights the efficiency of these supramolecular structures in applications related to infectious diseases and cancer.
Collapse
Affiliation(s)
- Rosa Bellavita
- Department of Pharmacy, University of Naples ‘Federico II', Naples 80131, Italy
| | - Simone Braccia
- Department of Pharmacy, University of Naples ‘Federico II', Naples 80131, Italy
| | - Annarita Falanga
- Department of Agricultural Sciences, University of Naples ‘Federico II', Portici 80055, Italy
| | - Stefania Galdiero
- Department of Pharmacy, University of Naples ‘Federico II', Naples 80131, Italy
| |
Collapse
|
2
|
Wu KY, Ashkar S, Jain S, Marchand M, Tran SD. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma. Polymers (Basel) 2023; 15:polym15061373. [PMID: 36987154 PMCID: PMC10054733 DOI: 10.3390/polym15061373] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 02/25/2023] [Accepted: 03/06/2023] [Indexed: 03/12/2023] Open
Abstract
The eye has anatomical structures that function as robust static and dynamic barriers, limiting the penetration, residence time, and bioavailability of medications administered topically. The development of polymeric nano-based drug-delivery systems (DDS) could be the solution to these challenges: it can pass through ocular barriers, offering higher bioavailability of administered drugs to targeted tissues that are otherwise inaccessible; it can stay in ocular tissues for longer periods of time, requiring fewer drug administrations; and it can be made up of polymers that are biodegradable and nano-sized, minimizing the undesirable effects of the administered molecules. Therefore, therapeutic innovations in polymeric nano-based DDS have been widely explored for ophthalmic drug-delivery applications. In this review, we will give a comprehensive overview of polymeric nano-based drug-delivery systems (DDS) used in the treatment of ocular diseases. We will then examine the current therapeutic challenges of various ocular diseases and analyze how different types of biopolymers can potentially enhance our therapeutic options. A literature review of the preclinical and clinical studies published between 2017 and 2022 was conducted. Thanks to the advances in polymer science, the ocular DDS has rapidly evolved, showing great promise to help clinicians better manage patients.
Collapse
Affiliation(s)
- Kevin Y. Wu
- Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada; (K.Y.W.)
| | - Said Ashkar
- Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Shrieda Jain
- Department of Experimental Surgery, McGill University, Montreal, QC H3G 1A4, Canada
| | - Michael Marchand
- Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada; (K.Y.W.)
| | - Simon D. Tran
- Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC H3A 1G1, Canada
- Correspondence:
| |
Collapse
|
3
|
Nuić L, Panić B, Pereković LK, Rakić IŠ, Kralj M, Mihanović A, Vančik H, Biljan I. Polymerization of aromatic dinitroso derivatives initiated by nitroso-terminated monolayer on Au(111) surface: Insights from ellipsometry, AFM and nano-FTIR spectroscopy. POLYMER 2023. [DOI: 10.1016/j.polymer.2023.125795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
|
4
|
Oliveira AML, Machado M, Silva GA, Bitoque DB, Tavares Ferreira J, Pinto LA, Ferreira Q. Graphene Oxide Thin Films with Drug Delivery Function. NANOMATERIALS 2022; 12:nano12071149. [PMID: 35407267 PMCID: PMC9000550 DOI: 10.3390/nano12071149] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Revised: 03/24/2022] [Accepted: 03/28/2022] [Indexed: 02/04/2023]
Abstract
Graphene oxide has been used in different fields of nanomedicine as a manager of drug delivery due to its inherent physical and chemical properties that allow its use in thin films with biomedical applications. Several studies demonstrated its efficacy in the control of the amount and the timely delivery of drugs when it is incorporated in multilayer films. It has been demonstrated that oxide graphene layers are able to work as drug delivery or just to delay consecutive drug dosage, allowing the operation of time-controlled systems. This review presents the latest research developments of biomedical applications using graphene oxide as the main component of a drug delivery system, with focus on the production and characterization of films, in vitro and in vivo assays, main applications of graphene oxide biomedical devices, and its biocompatibility properties.
Collapse
Affiliation(s)
- Alexandra M. L. Oliveira
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
- Correspondence: (A.M.L.O.); (Q.F.)
| | - Mónica Machado
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Gabriela A. Silva
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Diogo B. Bitoque
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Joana Tavares Ferreira
- Ophthalmology Department, Centro Hospitalar Universitário de Lisboa Norte, 1649-035 Lisbon, Portugal; (J.T.F.); (L.A.P.)
- Visual Sciences Study Centre, Faculty of Medicine, Universidade de Lisboa, 1649-028 Lisbon, Portugal
| | - Luís Abegão Pinto
- Ophthalmology Department, Centro Hospitalar Universitário de Lisboa Norte, 1649-035 Lisbon, Portugal; (J.T.F.); (L.A.P.)
- Visual Sciences Study Centre, Faculty of Medicine, Universidade de Lisboa, 1649-028 Lisbon, Portugal
| | - Quirina Ferreira
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- Correspondence: (A.M.L.O.); (Q.F.)
| |
Collapse
|
5
|
Hatamie S, Shih PJ, Chen BW, Wang IJ, Young TH, Yao DJ. Synergic Effect of Novel WS 2 Carriers Holding Spherical Cobalt Ferrite @cubic Fe 3O 4 (WS 2/s-CoFe 2O 4@c-Fe 3O 4) Nanocomposites in Magnetic Resonance Imaging and Photothermal Therapy for Ocular Treatments and Investigation of Corneal Endothelial Cell Migration. NANOMATERIALS (BASEL, SWITZERLAND) 2020; 10:E2555. [PMID: 33352770 PMCID: PMC7766809 DOI: 10.3390/nano10122555] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Revised: 12/14/2020] [Accepted: 12/16/2020] [Indexed: 12/18/2022]
Abstract
The design of novel materials to use simultaneously in an ocular system for driven therapeutics and wound healing is still challenging. Here, we produced nanocomposites of tungsten disulfide carriers with spherical cobalt ferrite nanoparticles (NPs) as core inside a cubic iron oxide NPs shell (WS2/s-CoFe2O4@c-Fe3O4). Transmission electron microscopy (TEM) confirmed that 10 nm s-CoFe2O4@c-Fe3O4 NPs were attached on the WS2 sheet surfaces. The cytotoxicity of the WS2 sheets and nanocomposites were evaluated on bovine cornea endothelial cells (BCECs) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for a duration of three days. The MTT assay results showed low toxicity of the WS2 sheets on BCECs by 67% cell viability at 100 μg/mL in 24 h, while the nanocomposites show 50% cell viability in the same conditions. The magnetic resonance imaging (MRI) of nanocomposites revealed the excellent T2-weighted imaging with an r2 contrast of 108 mM-1 S-1. The in vitro photothermal therapy based on WS2 sheets and WS2/s-CoFe2O4 @c-Fe3O4 nanocomposites using 808 nm laser showed that the maximum thermal energy dispatched in medium at different applied power densities (1200 mw, 1800, 2200, 2600 mW) was for 0.1 mg/mL of the sample solution. The migration assay of BCECs showed that the wound healing was approximately 20% slower for the cell exposed by nanocomposites compared with the control (no exposed BCECs). We believe that WS2/s-CoFe2O4@c-Fe3O4 nanocomposites have a synergic effect as photothermal therapy agents for eye diseases and could be a target in an ocular system using MRI.
Collapse
Affiliation(s)
- Shadie Hatamie
- College of Medicine, National Taiwan University, Taipei 10048, Taiwan;
- Department of Biomedical Engineering, National Taiwan University, Taipei 10617, Taiwan;
| | - Po-Jen Shih
- Department of Biomedical Engineering, National Taiwan University, Taipei 10617, Taiwan;
| | - Bo-Wei Chen
- Institute of Nanoengineering and Microsystem, National Tsing Hua University, Hsinchu 30013, Taiwan; (B.-W.C.); (D.-J.Y.)
| | - I-Jong Wang
- College of Medicine, National Taiwan University, Taipei 10048, Taiwan;
| | - Tai-Horng Young
- Department of Biomedical Engineering, National Taiwan University, Taipei 10617, Taiwan;
| | - Da-Jeng Yao
- Institute of Nanoengineering and Microsystem, National Tsing Hua University, Hsinchu 30013, Taiwan; (B.-W.C.); (D.-J.Y.)
| |
Collapse
|
6
|
Yu H, Wu W, Lin X, Feng Y. Polysaccharide-Based Nanomaterials for Ocular Drug Delivery: A Perspective. Front Bioeng Biotechnol 2020; 8:601246. [PMID: 33363130 PMCID: PMC7758246 DOI: 10.3389/fbioe.2020.601246] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Accepted: 11/05/2020] [Indexed: 12/30/2022] Open
Abstract
Ocular drug delivery is one of the most challenging issues in ophthalmology because of the complex physiological structure of the eye. Polysaccharide-based nanomaterials have been extensively investigated in recent years as ideal carriers for enhancing the bioavailability of drugs in the ocular system because of their biocompatibility and drug solubilization. From this perspective, we discuss the structural instability of polysaccharides and its impact on the synthesis process; examine the potential for developing bioactive polysaccharide-based ocular drug nanocarriers; propose four strategies for designing novel drug delivery nanomaterials; and suggest reviewing the behavior of nanomaterials in ocular tissues.
Collapse
Affiliation(s)
- Haozhe Yu
- Institute of Medical Technology, Peking University Health Science Center, Beijing, China
- Department of Ophthalmology, Peking University Third Hospital, Beijing, China
| | - Wenyu Wu
- Department of Ophthalmology, Peking University Third Hospital, Beijing, China
| | - Xiang Lin
- School of Chinese Medicine, The University of Hong Kong, Hong Kong, China
| | - Yun Feng
- Institute of Medical Technology, Peking University Health Science Center, Beijing, China
- Department of Ophthalmology, Peking University Third Hospital, Beijing, China
| |
Collapse
|
7
|
Iqbal S, Qu Y, Dong Z, Zhao J, Rauf Khan A, Rehman S, Zhao Z. Poly (β‐amino esters) based potential drug delivery and targeting polymer; an overview and perspectives (review). Eur Polym J 2020. [DOI: 10.1016/j.eurpolymj.2020.110097] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|